264 related articles for article (PubMed ID: 20413099)
41. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
42. Contemporary Ribonomics Methods for Viral microRNA Target Analysis.
Gay LA; Turner PC; Renne R
Noncoding RNA; 2018 Nov; 4(4):. PubMed ID: 30424002
[TBL] [Abstract][Full Text] [Related]
43. microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.
Sethuraman S; Gay LA; Jain V; Haecker I; Renne R
PLoS Pathog; 2017 Jul; 13(7):e1006508. PubMed ID: 28715488
[TBL] [Abstract][Full Text] [Related]
44. Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators.
Guo YE; Oei T; Steitz JA
J Virol; 2015 Nov; 89(21):10901-11. PubMed ID: 26292323
[TBL] [Abstract][Full Text] [Related]
45. Viral miRNA targeting of bicistronic and polycistronic transcripts.
Zhu Y; Huang Y; Jung JU; Lu C; Gao SJ
Curr Opin Virol; 2014 Aug; 7():66-72. PubMed ID: 24821460
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.
Campbell AM; De La Cruz-Herrera CF; Marcon E; Greenblatt J; Frappier L
PLoS Pathog; 2022 Jan; 18(1):e1010235. PubMed ID: 35007297
[TBL] [Abstract][Full Text] [Related]
48. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
[TBL] [Abstract][Full Text] [Related]
49. A viral microRNA functions as an orthologue of cellular miR-155.
Gottwein E; Mukherjee N; Sachse C; Frenzel C; Majoros WH; Chi JT; Braich R; Manoharan M; Soutschek J; Ohler U; Cullen BR
Nature; 2007 Dec; 450(7172):1096-9. PubMed ID: 18075594
[TBL] [Abstract][Full Text] [Related]
50. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
51. EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape.
Ungerleider N; Bullard W; Kara M; Wang X; Roberts C; Renne R; Tibbetts S; Flemington EK
PLoS Pathog; 2021 May; 17(5):e1009217. PubMed ID: 33956915
[TBL] [Abstract][Full Text] [Related]
52. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
53. Murine cytomegalovirus infection of cultured mouse cells induces expression of miR-7a.
Dittmer A; Förstemann K
J Gen Virol; 2012 Jul; 93(Pt 7):1537-1547. PubMed ID: 22442111
[TBL] [Abstract][Full Text] [Related]
54. EBV-encoded miRNAs.
Barth S; Meister G; Grässer FA
Biochim Biophys Acta; 2011; 1809(11-12):631-40. PubMed ID: 21640213
[TBL] [Abstract][Full Text] [Related]
55. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.
Nachmani D; Stern-Ginossar N; Sarid R; Mandelboim O
Cell Host Microbe; 2009 Apr; 5(4):376-85. PubMed ID: 19380116
[TBL] [Abstract][Full Text] [Related]
56. In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.
Whisnant AW; Bogerd HP; Flores O; Ho P; Powers JG; Sharova N; Stevenson M; Chen CH; Cullen BR
mBio; 2013 Apr; 4(2):e000193. PubMed ID: 23592263
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus circRNAome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis.
Qiao Y; Zhao X; Liu J; Yang W
Bioengineered; 2019 Dec; 10(1):593-603. PubMed ID: 31668120
[TBL] [Abstract][Full Text] [Related]
58. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
59. Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.
Jha HC; Lu J; Verma SC; Banerjee S; Mehta D; Robertson ES
mBio; 2014 Dec; 5(6):. PubMed ID: 25516617
[TBL] [Abstract][Full Text] [Related]
60. Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.
Schifano JM; Corcoran K; Kelkar H; Dittmer DP
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
